Beijing Tongrentang Co Ltd
SSE:600085

Watchlist Manager
Beijing Tongrentang Co Ltd Logo
Beijing Tongrentang Co Ltd
SSE:600085
Watchlist
Price: 41.4 CNY -1.43%
Market Cap: 56.8B CNY
Have any thoughts about
Beijing Tongrentang Co Ltd?
Write Note

Beijing Tongrentang Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Tongrentang Co Ltd
Cost of Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Tongrentang Co Ltd
SSE:600085
Cost of Revenue
-ÂĄ9.8B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cost of Revenue
-ÂĄ1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cost of Revenue
-ÂĄ5.9B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cost of Revenue
-ÂĄ3.9B
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cost of Revenue
-ÂĄ28.7B
CAGR 3-Years
-3%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cost of Revenue
-ÂĄ242.3m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Beijing Tongrentang Co Ltd's Cost of Revenue?
Cost of Revenue
-9.8B CNY

Based on the financial report for Jun 30, 2024, Beijing Tongrentang Co Ltd's Cost of Revenue amounts to -9.8B CNY.

What is Beijing Tongrentang Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-6%

Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Beijing Tongrentang Co Ltd have been -8% over the past three years , -5% over the past five years , and -6% over the past ten years .

Back to Top